Cargando…

Identification of Tumor Antigens and Immune Landscape in Glioblastoma for mRNA Vaccine Development

Background: Clinical benefits from standard therapies against glioblastoma (GBM) are limited in part due to the intrinsic radio- and chemo-resistance. As an essential part of tumor immunotherapy for adjunct, therapeutic tumor vaccines have been effective against multiple solid cancers, while their e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Liguo, Wang, Long, Yang, Ji’an, Hu, Ping, Zhang, Chunyu, Tong, Shi’ao, Liu, Zhennan, Tian, Daofeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435740/ https://www.ncbi.nlm.nih.gov/pubmed/34527020 http://dx.doi.org/10.3389/fgene.2021.701065

Ejemplares similares

Identification of tumor antigens and immune subtypes in lower grade gliomas for mRNA vaccine development
por: Ye, Liguo, et al.
Publicado: (2021)

Downregulation of CYP2E1 is associated with poor prognosis and tumor progression of gliomas
por: Ye, Liguo, et al.
Publicado: (2021)

Identification of Tumor Antigens and Immune Subtypes of Esophageal Squamous Cell Carcinoma for mRNA Vaccine Development
por: Lu, Tong, et al.
Publicado: (2022)

Integrated Analysis to Evaluate the Prognostic Value of Signature mRNAs in Glioblastoma Multiforme
por: Yang, Ji’an, et al.
Publicado: (2020)

Identification and validation of a novel prognostic signature based on mitochondria and oxidative stress related genes for glioblastoma
por: Tong, Shiao, et al.
Publicado: (2023)

Tumor Immune Microenvironment Landscape in Glioma Identifies a Prognostic and Immunotherapeutic Signature
por: Zhang, Chunyu, et al.
Publicado: (2021)

Identification of a Five-mRNA Signature as a Novel Potential Prognostic Biomarker for Glioblastoma by Integrative Analysis
por: Xu, Huifang, et al.
Publicado: (2022)

Identification of Tumor Antigens and Immune Subtypes of Glioblastoma for mRNA Vaccine Development
por: Lin, Han, et al.
Publicado: (2022)

Tumor-antigens and immune landscapes identification for prostate adenocarcinoma mRNA vaccine
por: Zheng, Xiaonan, et al.
Publicado: (2021)

Immunophenotypic Landscape and Prognosis-Related mRNA Signature in Diffuse Large B Cell Lymphoma
por: Jiang, Yanan, et al.
Publicado: (2022)

Identification and validation of a 17-gene signature to improve the survival prediction of gliomas
por: Tong, Shiao, et al.
Publicado: (2022)

A Novel Six-mRNA Signature Predicts Survival of Patients With Glioblastoma Multiforme
por: Liu, Zhentao, et al.
Publicado: (2021)

An Inflammatory Landscape for Preoperative Neurologic Deficits in Glioblastoma
por: Katrib, Amal, et al.
Publicado: (2019)

Identification of tumor antigens and immune landscapes for bladder urothelial carcinoma mRNA vaccine
por: Sun, Zhuolun, et al.
Publicado: (2023)

Identification of CircRNA–miRNA–mRNA Regulatory Network in Gastrointestinal Stromal Tumor
por: Zou, Fang-wen, et al.
Publicado: (2020)

Cryopreservation Induces Alterations of miRNA and mRNA Fragment Profiles of Bull Sperm
por: Shangguan, Aishao, et al.
Publicado: (2020)

Identification of mRNA Signature for Predicting Prognosis Risk of Rectal Adenocarcinoma
por: Jiang, Linlin, et al.
Publicado: (2022)

Identification of Novel Tumor Antigens and the Immune Landscapes of Bladder Cancer Patients for mRNA Vaccine Development
por: Wang, Guixin, et al.
Publicado: (2022)

mRBioM: An Algorithm for the Identification of Potential mRNA Biomarkers From Complete Transcriptomic Profiles of Gastric Adenocarcinoma
por: Dong, Changlong, et al.
Publicado: (2021)

Tumor antigens and immune subtypes of glioblastoma: the fundamentals of mRNA vaccine and individualized immunotherapy development
por: Wu, Changwu, et al.
Publicado: (2022)

Multiomics Analysis Reveals the Prognostic Non-tumor Cell Landscape in Glioblastoma Niches
por: Xiao, Zixuan, et al.
Publicado: (2021)

Integrated Transcriptomic Analysis of the miRNA–mRNA Interaction Network in Thin Endometrium
por: Zong, Lu, et al.
Publicado: (2021)

Identification of tumor-associated antigens and immune subtypes of lower-grade glioma and glioblastoma for mRNA vaccine development
por: Wang, Zhi-liang, et al.
Publicado: (2022)

Identification of Alternative Polyadenylation in Cyanidioschyzon merolae Through Long-Read Sequencing of mRNA
por: Schärfen, Leonard, et al.
Publicado: (2022)

Analysis of mRNA m(6)A modification and mRNA expression profiles in middle ear cholesteatoma
por: Xie, Shumin, et al.
Publicado: (2023)

Elimination of wild-type P53 mRNA in glioblastomas showing heterozygous mutations of P53
por: Szybka, M, et al.
Publicado: (2008)

Identification of circulating immune landscape in ischemic stroke based on bioinformatics methods
por: Li, Danyang, et al.
Publicado: (2022)

Eukaryotic mRNA Decapping Activation
por: Vidya, Elva, et al.
Publicado: (2022)

Identification of miRNA–mRNA–TFs Regulatory Network and Crucial Pathways Involved in Tetralogy of Fallot
por: You, Guoling, et al.
Publicado: (2020)

Identification of the circRNA–miRNA–mRNA regulatory network in osteoarthritis using bioinformatics analysis
por: Xu, Wen-Bin, et al.
Publicado: (2022)

Integrated Analysis of Hepatic miRNA and mRNA Expression Profiles in the Spontaneous Reversal Process of Liver Fibrosis
por: Tai, Yang, et al.
Publicado: (2021)

Identification of an Immune-Related Prognostic Risk Model in Glioblastoma
por: Lin, Zhiying, et al.
Publicado: (2022)

The Identification and Analysis of mRNA–lncRNA–miRNA Cliques From the Integrative Network of Ovarian Cancer
por: Zhou, You, et al.
Publicado: (2019)

In silico Identification of 10 Hub Genes and an miRNA–mRNA Regulatory Network in Acute Kawasaki Disease
por: Ma, Jin, et al.
Publicado: (2021)

Systematic Identification of circRNA–miRNA–mRNA Regulatory Network in Esophageal Squamous Cell Carcinoma
por: Shen, Yi, et al.
Publicado: (2021)

Identification of Ion Channel-Related Genes and miRNA-mRNA Networks in Mesial Temporal Lobe Epilepsy
por: Su, Zhengwei, et al.
Publicado: (2022)

IRF2-ferroptosis related gene is associated with prognosis and EMT in gliomas()
por: Tong, Shiao, et al.
Publicado: (2022)

Identification of the Immune Cell Infiltration Landscape in Hepatocellular Carcinoma to Predict Prognosis and Guide Immunotherapy
por: Yang, Shiyan, et al.
Publicado: (2021)

Identification of Tumor Antigens and Immune Subtypes in Lung Adenocarcinoma for mRNA Vaccine Development
por: Xu, Ran, et al.
Publicado: (2022)

Adverse Reaction to COVID-19 mRNA Vaccination in a Patient With VEXAS Syndrome
por: Ciprian, Giulio
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f0b9hummbal6ptdriimflp7po3